Related references
Note: Only part of the references are listed.Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice
Daisuke Kurotaki et al.
BLOOD (2019)
Blastic Plasmacytoid Dendritic Cell Neoplasm
Daniel Kerr et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D. DiNardo et al.
BLOOD (2019)
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
Maria Rosaria Sapienza et al.
HAEMATOLOGICA (2019)
Clonal evolution in the transition from cutaneous disease to acute leukemia suggested by liquid biopsy in blastic plasmacytoid dendritic cell neoplasm
Eleni Ladikou et al.
HAEMATOLOGICA (2018)
An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality
Lhara Sumarriva Lezama et al.
HISTOPATHOLOGY (2018)
Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation
Venetia Bigley et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response
Kana Sakamoto et al.
LEUKEMIA (2018)
8q24/&ITMYC&IT rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms
Prajwal C. Boddu et al.
LEUKEMIA RESEARCH (2018)
Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells
Patrick Fernandes Rodrigues et al.
NATURE IMMUNOLOGY (2018)
Ikaros family zinc finger 1 regulates dendritic cell development and function in humans
Urszula Cytlak et al.
NATURE COMMUNICATIONS (2018)
Clonal evolution in the transition from cutaneous disease to acute leukemia suggested by liquid biopsy in blastic plasmacytoid dendritic cell neoplasm
Eleni Ladikou et al.
HAEMATOLOGICA (2018)
Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events
Zhenya Tang et al.
LEUKEMIA RESEARCH (2018)
Venetoclax in a Patient with a Blastic Plasmacytoid Dendritic-Cell Neoplasm
Mounzer E. Agha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies
Courtney D. DiNardo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia
Sarah Betrian et al.
HEMATOLOGICAL ONCOLOGY (2017)
Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate
Christian Arranto et al.
ANNALS OF HEMATOLOGY (2017)
Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax
Joan Montero et al.
CANCER DISCOVERY (2017)
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
Laure Philippe et al.
HAEMATOLOGICA (2017)
Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm
K. Suzuki et al.
LEUKEMIA (2017)
Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report
Solomiya Grushchak et al.
MEDICINE (2017)
BAD-LAMP controls TLR9 trafficking and signalling in human plasmacytoid dendritic cells
Alexis Combes et al.
NATURE COMMUNICATIONS (2017)
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
Laure Philippe et al.
HAEMATOLOGICA (2017)
Lineage specification of human dendritic cells is marked by IRF8 expression in hematopoietic stem cells and multipotent progenitors
Jaeyop Lee et al.
NATURE IMMUNOLOGY (2017)
Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm
Matthew L. Ulrickson et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Allogeneic Hematopoietic Stem Cell Transplantions in Blastic Plasmacytoid Dendritic Cell Neoplasm in first complete remission: an effective therapy for a rare disease
Uday Deotare et al.
LEUKEMIA & LYMPHOMA (2016)
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy
Uday Deotare et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms
Anouk Emadali et al.
BLOOD (2016)
LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis
Adam Ceroi et al.
BLOOD (2016)
A Druggable TCF4-and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Michele Ceribelli et al.
CANCER CELL (2016)
Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases
Raida Khwaja et al.
LEUKEMIA & LYMPHOMA (2016)
Neoplasms derived from plasmacytoid dendritic cells
Fabio Facchetti et al.
MODERN PATHOLOGY (2016)
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm
Tomohiro Aoki et al.
BLOOD (2015)
Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1
Tobias Hilbert et al.
MEDIATORS OF INFLAMMATION (2015)
KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm
Naery Yang et al.
CANCER GENETICS (2015)
Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile
Lourdes Martin-Martin et al.
ONCOTARGET (2015)
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
Fanny Angelot-Delettre et al.
HAEMATOLOGICA (2015)
Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review
Ravi Paluri et al.
HEMATOLOGICAL ONCOLOGY (2015)
Blastic Plasmacytoid Dendritic Cell Neoplasms Clinico-immunohistochemical Correlations in a Series of 91 Patients
Fanny Julia et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells
Eva Nievergall et al.
BLOOD (2014)
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients
Arthur E. Frankel et al.
BLOOD (2014)
Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-Azacytidine
Kamel Laribi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
J. Menezes et al.
LEUKEMIA (2014)
Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC
S. J. Busfield et al.
LEUKEMIA (2014)
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition
M. R. Sapienza et al.
LEUKEMIA (2014)
Dendritic cell fate is determined by BCL11A
Gregory C. Ippolito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm
Albrecht Stenzinger et al.
ONCOTARGET (2014)
TET2 Mutations, Myelodysplastic Features, and A Distinct Immunoprofile Characterize Blastic Plasmacytoid Dendritic Cell Neoplasm in the Bone Marrow
Khaled Alayed et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Lung involvement at initial presentation in blastic plasmacytoid dendritic cell neoplasm lacking cutaneous lesion
Koji Endo et al.
ANNALS OF HEMATOLOGY (2013)
Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation
Mohamed A. Kharfan-Dabaja et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms
Santiago Montes-Moreno et al.
BLOOD (2013)
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation
Damien Roos-Weil et al.
BLOOD (2013)
BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells
Leonardo Boiocchi et al.
BLOOD (2013)
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients
F. Julia et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm
Berengere Gruson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
Livio Pagano et al.
HAEMATOLOGICA (2013)
Blastic Plasmacytoid Dendritic Cell Neoplasm without Cutaneous Lesion at Presentation: Case Report and Literature Review
Huijie Wang et al.
ACTA HAEMATOLOGICA (2012)
Specific Skin Lesions in Chronic Myelomonocytic Leukemia A Spectrum of Myelomonocytic and Dendritic Cell Proliferations. A Study of 42 Cases
Franck Vitte et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Blastic plasmacytoid dendritic cell neoplasm
Fanny Angelot-Delettre et al.
BLOOD (2012)
The transcription factor Spi-B regulates human plasmacytoid dendritic cell survival through direct induction of the antiapoptotic gene BCL2-A1
Julien J. Karrich et al.
BLOOD (2012)
ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events
Claudia Haferlach et al.
GENES CHROMOSOMES & CANCER (2012)
Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm
Lila Gilis et al.
LEUKEMIA & LYMPHOMA (2012)
The first case of blastic plasmacytoid dendritic cell neoplasm with MLL-ENL rearrangement
Takashi Toya et al.
LEUKEMIA RESEARCH (2012)
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review
Michael J. Rauh et al.
LEUKEMIA RESEARCH (2012)
Histologic and Immunohistologic Characterization of Skin Localization of Myeloid Disorders A Study of 173 Cases
Claire Benet et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion
Marco Lucioni et al.
BLOOD (2011)
TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm
Fabrice Jardin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm
Jean-Louis Dargent et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2011)
Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm-Morphologic and Phenotypic Variability in a Series of 33 Patients
Carlo Cota et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications
Armin G. Jegalian et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Continuous Expression of the Transcription Factor E2-2 Maintains the Cell Fate of Mature Plasmacytoid Dendritic Cells
Hiyaa S. Ghosh et al.
IMMUNITY (2010)
Alterations of the Cell-Cycle Inhibitors p27(KIP1) and p16(INK4a) Are Frequent in Blastic Plasmacytoid Dendritic Cell Neoplasms
Thomas Wiesner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group
Nikolaos J. Tsagarakis et al.
LEUKEMIA RESEARCH (2010)
Plasmacytoid Dendritic Cells Physiologic Roles and Pathologic States
Armin G. Jegalian et al.
ADVANCES IN ANATOMIC PATHOLOGY (2009)
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+haematodermic neoplasms and contribute to the aggressiveness of the disease
F. Jardin et al.
LEUKEMIA (2009)
TET2 mutations in myelodysplasia and myeloid malignancies
Charles G. Mullighan
NATURE GENETICS (2009)
Novel markers of normal and neoplastic human plasmacytoid dendritic cells
Teresa Marafioti et al.
BLOOD (2008)
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate
Justin J. Leitenberger et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
CD4+/CD56+ hematodermic neoplasm (blastic natural killer cell lymphoma):: Neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon
Monika E. Pilichowska et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer
Chalid Assaf et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities
Remco Dijkman et al.
BLOOD (2007)
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients
S. A. Pileri et al.
LEUKEMIA (2007)
The BCL11AXL transcription factor:: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells
K. Pulford et al.
LEUKEMIA (2006)
CD4+/CD56+ hematologic malignancy with rearranged MLL gene
R Leung et al.
HUMAN PATHOLOGY (2006)
Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells
L Gopcsa et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor) - Prognostication and categorization according to anatomic sites of involvement
R Suzuki et al.
CANCER (2005)
Blastic NK-cell lymphomas (agranular CD4+CD56+hematodermic neoplasms) - A review
T Petrella et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma
T Maeda et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis
T Petrella et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature
MW Bekkenk et al.
ANNALS OF ONCOLOGY (2004)
Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin - A morphologic, immunophenotypic, and molecular study of 50 patients
C Massone et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders
W Vermi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia
YC Chen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Neoplasms derived from plasmacytoid monocytes/interferon-producing cells: Variability of CD56 and granzyme B expression
F Facchetti et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
What is CD4+CD56+malignancy and how should it be treated?
P Reimer et al.
BONE MARROW TRANSPLANTATION (2003)
Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more?
DV Kazakov et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin
M Hering et al.
BLOOD (2003)
'Agranular CD4+CD56+hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+precursor cells related to plasmacytoid monocytes
T Petrella et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets:: a study of 21 cases by the Groupie Francais de Cytogenetique Hematologique
D Leroux et al.
BLOOD (2002)
Clinical and biologic features of CD4(+)CD56(+) malignancies
J Feuillard et al.
BLOOD (2002)
Identification of a leukemic counterpart of the plasmacytoid dendritic cells
L Chaperot et al.
BLOOD (2001)
Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent THI polarization
M Cella et al.
NATURE IMMUNOLOGY (2000)
Share Paper
